These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 646562)

  • 1. Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections.
    Kancir LM; Tuazon CU; Cardella TA; Sheagren JN
    Arch Intern Med; 1978 Jun; 138(6):909-11. PubMed ID: 646562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative toxicities of methicillin and nafcillin.
    Kitzing W; Nelson JD; Mohs E
    Am J Dis Child; 1981 Jan; 135(1):52-5. PubMed ID: 7006381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of nafcillin-associated nephritis. A prospective analysis of 210 patients.
    Barriere SL; Conte JE
    West J Med; 1980 Dec; 133(6):472-7. PubMed ID: 7467307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia.
    Nolan CM; Abernathy RS
    Arch Intern Med; 1977 Aug; 137(8):997-1000. PubMed ID: 879956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nafcillin therapy for Staphylococcus aureus endocarditis.
    Masur H; Murray HW; Roberts RB
    Antimicrob Agents Chemother; 1978 Sep; 14(3):457-61. PubMed ID: 708023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis.
    Gentry CA; Rodvold KA; Novak RM; Hershow RC; Naderer OJ
    Pharmacotherapy; 1997; 17(5):990-7. PubMed ID: 9324187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible
    Chan L; Chan-Tompkins NH; Como J; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):662-668. PubMed ID: 31888347
    [No Abstract]   [Full Text] [Related]  

  • 10. The choice of a parenteral panicillinase-resistant penicillin.
    Med Lett Drugs Ther; 1969 Apr; 11(8):35-6. PubMed ID: 5778362
    [No Abstract]   [Full Text] [Related]  

  • 11. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
    Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
    Martínez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nafcillin treatment of Staphylococcus aureus meningitis.
    Ruiz DE; Warner JF
    Antimicrob Agents Chemother; 1976 Mar; 9(3):554-5. PubMed ID: 1259413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.
    Youngster I; Shenoy ES; Hooper DC; Nelson SB
    Clin Infect Dis; 2014 Aug; 59(3):369-75. PubMed ID: 24785233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
    Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP
    J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus bacteremia and endocarditis.
    Chang FY
    J Microbiol Immunol Infect; 2000 Jun; 33(2):63-8. PubMed ID: 10917874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis.
    Suh L; Coffin S; Leckerman KH; Gelfand JM; Honig PJ; Yan AC
    Pediatr Dermatol; 2008; 25(5):528-34. PubMed ID: 18950393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children.
    Kaplan SL; Mason EO; Feigin RD
    South Med J; 1982 Feb; 75(2):138-42. PubMed ID: 7036354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.